NCT02291861
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Teva Investigational Site 145 Tuscaloosa, Alabama, United States
- Teva Investigational Site 107 Anaheim, California, United States
- Teva Investigational Site 108 Anaheim, California, United States
- Teva Investigational Site 123 Glendale, California, United States